Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2014. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) rather than a financial results announcement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding share ownership changes.
Material Changes
The only material change disclosed is a transfer of 5,326 Ordinary shares by Mrs. V A Whyte to her connected person, Mr. I Whyte, by way of gift on May 9, 2014.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It is a compliance notification under the Disclosure and Transparency Rules.
Investor Verification Points
- Verify the date of the share transfer (May 9, 2014) and the notification date (May 12, 2014).
- Confirm the nature of the transaction as a gift between a PDMR and a connected person.
- Note that this filing does not contain financial performance data for the period.